Transport saline | Oocyte
Collection Medium | Oocyte Maturation
Medium
TL solutions | TALP media | 10X SP-TL
| 90% Percoll | KSOM
| CR1aa
| SOF
Transport Saline (0.9%)
Prepare 0.9% saline (9 g NaCl per liter)
in double distilled water and autoclave. Label as "Sterile 0.9%
saline, date made" and store indefinitely at 4°C.
Oocyte
Collection Medium (OCM)
1. Dissolve
TCM-199 powder (without phenol red, and without glutamine) (Hyclone) for 10
L and 3.50 g NaHCO3in 9 L ddH2O. Adjust pH to
7.2-7.4 and bring volume to 10 L. Sterile-filter 400 ml medium into 500
ml bottles and keep indefinitely at 4°C. Labels should read "Oocyte
Collection Medium, - Supplements and date made".
2. On night before use, add the following: 1 aliquot of stock 4: BSS+Hep, 1 aliquot of stock 11: glutamine (4 ml), and 1 aliquot of stock 15: Pen/Strep (4 ml). Change label to "+supplements", change date and use within a week.
Oocyte
Maturation Medium
1. Prepare 87 ml aliquots of TCM-199. and store at 4°C until use.
2. On night before use, add the
following to an aliquot of
1 aliquot stock 3: BSS
1 aliquot stock 8: gentamicin
125 ml stock 6: Folltropin
200 ml stock 5: estradiol
1 ml stock
2: Na Pyruvate
1 ml stock
10: Glutamine
Change label to read "Oocyte maturation medium" and use within 1 week.
TL Solutions - For Making
TALPs
Note that these media can also be
purchased from
Caisson, Millipore or
Lonza (formerly
Biowhittaker).
1. To prepare media, mix the ingredients as described in Table 1 (all volumes are in milliliters), adjust the pH, check osmolarity (if osmometer is available) and sterile-filter the solution.
2. Write expiration date on the label (use within one week) and store at 4°C.
Table
1. Recipes for preparation of TL solutions
|
Ingredient |
Sp-TL |
HEPES-TL |
IVF-TL |
|
Water (ml) |
79.232 |
177.0 |
40.157 |
|
Stock 17: NaCl (ml) |
4.34 |
10.0 |
2.5 |
|
Stock 18: KCl (ml) |
1.96 |
4.0 |
1.0 |
|
Stock 19: bicarb (ml) |
10.00 |
1.6 |
5.0 |
|
Stock 20: phosphate (ml) |
1.0 |
2.0 |
0.50 |
|
Stock 1: Na-lactate (ml) |
0.368 |
0.372 |
0.093 |
|
Stock 21: HEPES (ml) |
1.0 |
2.0 |
0 |
|
Stock 22: Ca chloride (ml) |
1.0 |
2.0 |
0.50 |
|
Stock 23: Mg chlor (ml) |
1.10 |
1.0 |
0.25 |
|
pH |
7.4 |
7.3 |
7.4 |
|
Osmolarity (mOsm) |
295-305 |
275-285 |
290-300 |
TALP (Tyrode’s Albumin
Lactate Pyruvate) Media
Recipe 1: using media from Caisson. Click
for the formulation.
1. To prepare media, mix the ingredients as described in Table 2 and sterile-filter the solution.
2. Write expiration date on the label (use within one week) and store at 4°C.
Table 2. Recipes for TALP media using Caisson media.
|
Ingredient |
Sp-TALP |
HEPES-TALP |
IVF-TALP |
|
TL (ml) |
76.0*** |
500.0 |
100.0 |
|
BSA, Fract V (g) |
0.48 |
1.5 |
0 |
|
BSA, EFAF (g)* |
0 |
0 |
0.6 |
|
Stock 2: pyruvate (ml) |
4.0 |
5.0 |
1.0 |
|
Stock 8: gentamicin (ml) |
160 |
750 |
100 |
|
Stock 7: heparin (ml) |
0 |
0 |
500*** |
Recipe 2: using
Millipore (Specialty Media)
media
1. To prepare media, mix the ingredients as described in Table 3 and sterile-filter the solution.
2. Write expiration date on the label (use within one week) and store at 4°C.
Table
3. Recipes for TALP Media using Specialty Media media.
|
Ingredient |
Sp-TALP |
HEPES-TALP |
IVF-TALP |
|
TL (ml) |
38.0*** |
100.0 |
50.0 |
|
BSA, Fract V (mg) |
240 |
300 |
0 |
|
BSA, EFAF (mg)* |
0 |
0 |
300 |
|
Stock 2: pyruvate (ml) |
2.0 |
1.0 |
0.5 |
|
Stock 8: gentamicin (ml) |
80 |
150 |
50 |
|
Stock 7: heparin (ml) |
0 |
0 |
250*** |
*
BSA, EFAF=essentially fatty-acid free Fraction V
** Save the 12 ml remaining
after preparation of medium since it can be used for Percoll preparation.
*** The optimal heparin concentration will vary between bulls - if one bull is used frequently, test various concentrations of heparin in a preliminary experiment.
10X SP-TL
1. Prepare 10x SP-TL stock solution by
dissolving the following in 100 ml water:
NaCl - 4.675 g
KCl - 0.23 g
NaH2PO4+H2O - 0.40 g
HEPES 2.38 g
2. Adjust pH to ~7.3, sterile filter and store indefinitely at 4°C.
90 %
Percoll
1. Place 4 ml of 10X SP-TL in a small
beaker and add 0.084 g sodium bicarbonate and 90 ml Na lactate (Stock 1).
2. Stir until bicarbonate dissolves.
3. Add 36 ml Percoll.
4. Add 158 ml MgCl2 (Stock 12) and 78 ml CaCl2 (Stock 13).
5. While stirring, adjust pH to 7.3-7.45 and
filter with a 0.45 mm filter (50 ml
filter tube or similar bottle-top filter). If a precipitate forms in
the Percoll solution, continue to stir. If compounds do not re-dissolve,
then start over.
It is very easy to get
precipitation if acid or base is added too rapidly during the adjustment of
pH. Therefore, it is recommended that this step be done slowly.
KSOM-BE (Potassium Simplex Optimized Medium –
Bovine Embryo Modification 2)
Recipe 1 – using KSOM+AA from Caisson (without
pen/strep). Click for the formulation.
1. Purchase KSOM from Caisson Laboratories and store frozen. Once thawed, keep at 4°C for 2 weeks.
2. Add 1 ml pen/strep to a new bottle of thawed
KSOM.
3. To 5 ml of KSOM stock add:
EFAF BSA - 15 mg
(3.00 mg/ml)
Gentamicin stock 8A - 2.5 ml (0.5 ml/ml)
Nonessential amino acids, 100X - 25 ml
Recipe 2 – using KSOM from
Millipore
(contains pen/strep)
1. Purchase KSOM MR-106-D from and store frozen. Use with caution after the expiration date provided by the manufacturer. Once thawed, keep at 4°C for 2 weeks.
2.
To 5 ml of KSOM stock add:
EFAF BSA - 15 mg (3.00
mg/ml)
Gentamicin stock 8A - 2.5 ml (0.5 ml/ml)
Nonessential amino acids, 100X
- 25 ml
Note: This formulation is different than was previously described on this Webpage. Cell and Molecular Technologies has developed a new KSOM formulation that contains essential amino acids and half the required concentration of nonessential amino acids.
3.
Sterile filter medium through a 0.22 mm syringe filter into a sterile 10 ml
beaker. Use immediately.
CR1aa (an alternative culture medium)
Note: the patent for this medium is
held by Infigen
1. Make CR1 stock (prepare in a 100 ml volumetric flask):
NaCl
0.670 g
KCl
0.023 g
NaHCO3
0.220 g
Na
Pyruvate 0.004 g
Glutamine
0.015 g
Hemi-Ca Lactate 0.055 g
Add first 5 ingredients to volumetric
flask. Add water (~90 ml). Thoroughly dissolve constituents and
then add Hemi-Ca Lactate. Add remaining water. Store for up to 2
days at 4°C.
Note: constituents of this medium
are known to precipitate out of solution. To minimize the chances of this
occurring, make sure all constitutents are dissolved before adding hemi-Ca
lactate and use immediately after making. If a medium appears white
and cloudy, discard and start again.
2. To prepare CR1aa, add the following to 5 ml of CR1 stock:
EFAF BSA - 15 mg (3.00 mg/ml)
Gentamicin stock 8A - 2.5 ml (0.5 ml/ml)
Nonessential amino acids, 100X - 50 ml
Essential amino acids, 50X - 100 ml
Sterile filter medium through a 0.22 mm syringe filter into a sterile 10 ml beaker. Use immediately.
SOF (Synthetic
Oviduct Fluid)
This is based on the formulation of Fischer-Brown
et al. Zygote 10:341-348 (2002) except that the concentration of gentamicin
is altered and the BSA is essentially fatty acid free BSA. We purchase the medium as a custom
formulation from Millipore (BSS-046-D)and supplement the
medium with 0.4 mM sodium pyruvate, 20 μl/ml MEM non-essential
amino acids and 10 μl/ml BME essential amino acids, and 0.025 mg/ml
gentamicin sulfate (i.e., 10x more than used for KSOM-BE2-it is not clear that
this is the optimal concentration). Essentially Fatty-acid-free BSA is also
added to achieve a final concentration of 8 mg/ml BSA.
To make 200X Sodium Pyruvate:
0.88 g → 100 ml H2O→ Sterile Filter +
Store at 4 ْC for 1 month.
To make 50 ml (modified) SOF+ add:
0.25 ml 200X Sodium Pyruvate
1.0 ml MEM amino acids
0.5 ml BME Amino Acids
0.25 ml gentamicin sulfate
400 mg
EFAF-BSA
The recipe
for SOF is as follows (all concentrations are in mM unless stated)
CaCl2 2H2O 1.17
KCL 7.16
KH2PO4 1.19
MgCl2
6H2O 0.49
NaCl 107.7
NaHCO3 25.07
Na lactate (60% syrup) 3.3
Na pyruvate 0.4
BSA (mg/l) 8000
Gentamicin sulfate (U/l) 500 000
BME essential AA
(ml/l) 10
MEM
non-essential AA (ml/l) 20
this page was last updated 01-21-08
all original material for
this website © Rocio Rivera, Peter J. Hansen et al. 2000-2008Links to commercial sites do
not constitute endorsement by the authors or the